Since 2010, the FDA has withhold the stem cell treatment I need for my joint condition. In 2012, the doctors who invented the cell culturing technology sold it to a publicly traded company called Biorestorative Theraputics (BRTXQ), who intended to pursue FDA approval. The doctors continue to use the technique at a private clinic in the Cayman Islands, where I have been treated with it successfully.
Biorestorative completed a Phase I trial with good results and was approved for a Phase 2 trial in 2017, but since then has been unable to raise the millions in funding needed to begin the trial. It’s unclear why, but I suspect it’s because the economics of regulation will make it very expensive to commercialize the final product, and investors aren’t interested in taking a chance on it when they don’t know that it will work.
In 2020, the company declared bankruptcy and their stock crashed to $0.0001-$0.0002.
I check on the company periodically to monitor its progress toward approval. I’ve also considered investing in its stock, but had not done until a few days ago so despite my belief in their product because I don’t know if the company is viable for the reasons stated previously. In April I noticed their stock collapse and considered buying it, on some level recognizing a potential opportunity, but didn’t because I simply had no clue what I would have been doing, and couldn’t find out much about what was going on with the company. I’m trying not to dwell on not having made more effort to figure it out at the time, because if I had put that $500 in then, it would now be over $10M.
Last Wednesday night I did my periodic check up of the company on a whim, which led to my discovery of a small community of penny stock enthusiasts going manic over a 1000+% rise in the company’s stock in the last few weeks. In July their largest debt holder, an investment group who believes in the product’s potential, agreed to pay off all their other debt and provide the funding for the Phase 2 trial. I don’t understand the details, but people on the internet seem to think this is a huge, game-changing development. There is a bankruptcy reorganization plan that is expected to be approved Sept 10.
I had several thousand in a Fidelity account that I was waiting to put into gold stocks if I decided that it was warranted, but decided to put it into BRTXQ immediately because it looked like the recent move are based on real, positive changes, and the stock price is climbing radically every day. Fidelity blocked my trade at $0.011, and told me it was because the company was delinquent with its SEC filings, and they consider it too risky for their clients. I scrambled to get funds settled in another brokerage, and the stock almost doubled before I could buy it, but I finally got my shares on Friday at $0.019.
I invested a few thousand $$, which I can stand to lose if this turns out to be hype, but I don’t think it is. I say this because of my first-hand knowledge that the product works and fills a major unmet medical need, which is why investors are stepping up to save the company. There is hype to be sure, including a few social media accounts I found that were set up in the last few weeks on reddit, Twitter, and ihub just to hype the stock, but I don’t think it’s the dominant element of what’s happening.
So while I’m in, I’m not sure I’m in enough. This may warrant a greater risk. If the company achieves its goal of getting relisted and returns to its pre-bankruptcy prices, I could make 100x. I see it as an opportunity to profit from the evil that was done to me.
But the fart remains that I am not an investor nor a financial analyst and just plain have no idea what the Hell I’m doing. I have only ever invested in a small number of things that I know about or believe in. I know nothing about how to judge the stock of a company coming out of bankruptcy. All I know is their stuff works, and will be approved if the trials proceed. I have much more in savings than I invested, but due to circumstances, can’t stand to lose too much if this doesn’t work out.
Here are the notes from my very amateur analysis (formatting copied and pasted, emphasis not mine):
To buy, or not to buy?
-
PRO/upside
-
Cons/Risks
- QUESTIONS
Facts
-
Declared bankruptcy in March.
-
John M. Desmarais bid $500,000 in April
-
REORGANIZATION PLAN POSTED IN JULY.
-
July: THEN LAST MONTH, a large investment firm, AUCTUS Capital, threw a golden wrench into the bankruptcy process.
-
" THE DEBTOR AND AUCTUS, AS CO-PROPONENTS, URGE ALL CREDITORS TO VOTE TO ACCEPT THE PLAN BECAUSE IT IS ANTICIPATED TO PROVIDE A HIGHER AND MORE CERTAIN RETURN TO CREDITORS THAN ANY ALTERNATIVE. "
I would like to hear any thoughts you may have on this situation.